Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01829958 · ClinicalTrials.gov registry record · NA
Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy
A NA study of Diffuse Large B Cell Lymphoma (DLBCL) and Non Hodgkin Lymphoma (NHL), sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 201
- Enrollment target
- 8
- Study locations
NCT01829958 is a NA study of Diffuse Large B Cell Lymphoma (DLBCL) and Non Hodgkin Lymphoma (NHL) that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 201 participants, below the 243-participant average among 10 other Diffuse Large B Cell Lymphoma (DLBCL) trials with a reported enrollment target (17% lower). The trial reports 8 study locations across 2 states.
The verdict
NCT01829958, a NA study of Diffuse Large B Cell Lymphoma (DLBCL) and Non Hodgkin Lymphoma (NHL), is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study will evaluate the ability of a largely self-administered geriatric assessment (GA) to predict toxicity in non-Hodgkin Lymphoma (NHL) patients ≥60 years old receiving chemotherapy or chemoimmunotherapy.
Conditions Studied
Interventions
- DRUG prednisone
- BEHAVIORAL Geriatric Assessment
- DRUG rituximab
Study Locations (8)
New York
- Memorial Sloan Kettering Commack - Commack
- Memorial Sloan Kettering Westchester - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Rockville Centre - Rockville Centre
- Memorial Sloan Kettering Nassau - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge - Basking Ridge
- Memorial Sloan Kettering Monmouth - Middletown
- Memorial Sloan Kettering Bergen - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2013-04 |
| Est. Completion | 2026-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01829958
The ClinicalTrials.gov registry entry for NCT01829958 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 243-participant average among 10 other Diffuse Large B Cell Lymphoma (DLBCL) trials with a reported enrollment target (17% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diffuse Large B Cell Lymphoma (DLBCL) appearing as the primary indexed condition, and to 3 interventions - of which prednisone is the first listed.
NCT01829958 reports 8 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT01829958 about?
NCT01829958 is a clinical study titled "Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy". This study will evaluate the ability of a largely self-administered geriatric assessment (GA) to predict toxicity in non-Hodgkin Lymphoma (NHL) patients ≥60 years old receiving chemotherapy or chemoimmunotherapy.
What is the current status of trial NCT01829958?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 201 participants. The study started on 2013-04. Estimated completion is 2026-04.
What conditions does trial NCT01829958 study?
This clinical trial studies the following conditions: Diffuse Large B Cell Lymphoma (DLBCL), Non Hodgkin Lymphoma (NHL).
What interventions are being tested in trial NCT01829958?
The interventions under investigation include: prednisone (DRUG), Geriatric Assessment (BEHAVIORAL), rituximab (DRUG).
Who is sponsoring clinical trial NCT01829958?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01829958 being conducted?
This trial has 8 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diffuse Large B Cell Lymphoma (DLBCL)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RECRUITING · Phase 1
-
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
RECRUITING · Phase 2
-
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RECRUITING · Phase 3
-
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
RECRUITING · Phase 1
-
A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP
RECRUITING · Phase 2
-
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
ACTIVE NOT RECRUITING · Phase 3
Explore more on PlainTrial
Diffuse Large B Cell Lymphoma (DLBCL)
All registered trials for this condition
Non Hodgkin Lymphoma (NHL)
All registered trials for this condition
New Jersey
All trials with a study site in New Jersey
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.